Aurobindo Pharma receives Sebi’s warning letter over ongoing US FDA audit
The letter is in regards to certain disclosures made by the company on the ongoing FDA audit of company's Unit-I and observations…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Green packaging: A huge responsibility
As the world can't afford another Great Pacific Dump, the pharma industry needs to be responsible enough with its packaging…
Aurobindo Pharma Q4 net profit falls 28 per cent; revenue dips three per cent
The company had posted a consolidated net profit of Rs 801.18 crores in the same period of the preceding fiscal, Aurobindo Pharma…
Aurobindo Pharma gets US FDA nod for generic cancer drug Bortezomib
The product is the generic version of Reference Listed Drug (RLD) Velcade of Takeda Pharma
Aurobindo and Sun Pharma recall products in US market
While Aurobindo Pharma is recalling Cyanocobalamin injection, Sun Pharma is recalling a drug used to increase the production of…
Aurobindo Pharma acquires domestic formulations business of Veritaz Healthcare
The transaction, which comes into effect from 1st April, 2022, and is expected to close by May 2022, is agreed at a consideration…
Aurobindo and Sun Pharma recall products from US
While Aurobindo Pharma is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, Sun Pharma is recalling 59,232 bottles…
Aurobindo Pharma gets warning letter from US FDA for API facility
The action follows the recent inspection of the facility by the US Food and Drug Administration (FDA) in August 2021, the…
Aurobindo Pharma rolls out Molnaflu to treat adult COVID-19 patients
The pill is available pan-India across all major metros and towns
Aurobindo and Unichem recall products in US market
The affected lot contains 6.25 mg Carvedilol tablets, which have been produced in India and distributed in the US by…